ICOS agonism induces potent immune activation and anti-tumor response in non-clinical models

被引：1
|
作者：
Yadavilli, Sapna
Zhang, Tianqian
Hahn, Ashleigh
Seestaller-Wehr, Laura M.
Shi, Hong
Liu, Yao-Bin
DeYoung, M. Phillip
Kilian, David J.
Bi, Meixia
Adam, Michael P.
Zhang, Shu-Yun
Bhattacharya, Sabyasachi
Katlinskaya, Yuliya
Blackwell, Christina
Hopson, Christopher B.
Yanamandra, Niranjan
Srinivasan, Roopa
Mayes, Patrick A.
Hoos, Axel
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1637
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Activation of μ-opioid receptors in the hypothalamic paraventricular nucleus induces anti-tumor immune response
    Hamada, Yusuke
    Morita, Kana.
    Ito, Wataru
    Fujimori, Yuri
    Kanao, Naomi
    Yoshida, Sara
    Narita, Michiko
    Tamura, Hideki
    Suzuki, Masami
    Aoki, Kazunori
    Yamanaka, Akihiro
    Kuzumaki, Naoko
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S97 - S97
  • [2] NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
    Selvanesan, Benson Chellakkan
    Pulido, Alvaro de Mingo
    Varghese, Sheelu
    Rohila, Deepak
    Hupalo, Daniel
    Gusev, Yuriy
    Contente, Sara
    Wilkerson, Matthew D.
    Dalgard, Clifton L.
    Upadhyay, Geeta
    CANCERS, 2023, 15 (05)
  • [3] Non-clinical tumor models reveal broad combination potential of ICOS agonist antibodies
    Waight, Jeremy D.
    Bi, Meixia
    Kilian, David
    Hopson, Christopher
    Zhang, Shu-Yun
    Brett, Sara
    Yadavilli, Sapna
    Zhang, Tianqian
    Shi, Hong
    Hance, Kenneth W.
    Ballas, Marc
    Hoos, Axel
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Oncolytic adenovirus induces potent anti-tumor efficacy via robust activation of immune cells in bladder cancer
    Kim, Yunlim
    Lim, Bum Jin
    Yoon, A-Rum
    Yun, Chae-Ok
    Kim, Choung-Soo
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [5] Semaglutide as a potent activator of anti-tumor immune response in breast cancer
    Stanisavljevic, Isidora
    Jovanovic, Ivan
    Markovic, Bojana Simovic
    Corovic, Irfan
    Krajnovic, Tamara
    Mijatovic, Sanja
    Pavlovic, Sladjana
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 748 - 748
  • [6] Manipulation of T cell activation in the anti-tumor immune response
    Hurwitz, AA
    Leach, DR
    van Elsas, A
    Townsend, SE
    Allison, JP
    BIOLOGY OF TUMORS, 1998, : 213 - 222
  • [7] Intralesional Injection of Rose Bengal Induces an Anti-tumor Immune Response and Potent Tumor Regressions in a Murine Model of Colon Cancer
    Pardiwala, K.
    Qiao, G.
    Sundararajan, J.
    Prabhakar, B.
    Maker, A. V.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S86 - S86
  • [8] Lurbinectedin induces multimodal immune activation and augments the anti-tumor immune response in small-cell lung cancer
    Chakraborty, Subhamoy
    Mahendravarman, Yazhini
    Sen, Utsav
    Banerjee, Avisek
    Coleman, Charles
    Demircioglu, Deniz
    Hasson, Dan
    Sen, Triparna
    CANCER RESEARCH, 2024, 84 (06)
  • [9] The immune system as anti-tumor sentinel: Molecular requirements for an anti-tumor immune response
    Markiewicz, MA
    Gajewski, TF
    CRITICAL REVIEWS IN ONCOGENESIS, 1999, 10 (03): : 247 - 260
  • [10] Topical diphencyprone induces immune activation and anti-tumor effects in cutaneous neurofibromas
    Orloff, J.
    Seah, C.
    Poplausky, D.
    Block, B. R.
    Rivera-Oyola, R.
    Piontkowski, A.
    Powers, C. M.
    Young, J. N.
    Bose, S.
    Estrada, Y.
    Da Rosa, J. Correa
    Guttman-Yassky, E.
    Brown, R. M.
    Gulati, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S49 - S49
12345